AKT1 and colonic neoplasm: Previous studies also demonstrated Akt inhibition by pazopanib, ipatasertib or NVP-BEZ235 induced PUMA-dependent apoptosis in colon cancer through activating FoxO3a transcriptionally [32, 33, 51].